Sofferman R A, Nathan M H
Department of Surgery, The University of Vermont College of Medicine, Burlington 05401, USA.
Arch Otolaryngol Head Neck Surg. 1998 Jun;124(6):649-54. doi: 10.1001/archotol.124.6.649.
To evaluate the cumulative costs of failure to identify the ectopic parathyroid adenoma when exploration without preoperative localization is performed and to compare these costs with the expenses of routine preoperative localization in every patient.
A consecutive series of 59 patients with primary hyperparathyroidism studied with preoperative scans using technetium Tc 99m sestamibi and ultrasound was submitted to a cost analysis. A subset of 5 cases of ectopic adenomas, presumed to be unidentifiable on routine surgery, was similarly analyzed.
Academic tertiary referral center.
The operative, anesthesia, hospitalization, imaging, and physician reimbursement costs of a failed exploration are compared with the costs of preoperative technetium Tc 99m sestamibi and ultrasound scans in every patient.
Two cases of mediastinal parathyroid adenomas in this consecutive series of 59 patients were given a theoretical cost, including hospitalization, physician reimbursement, and anesthesia fees. These costs were based on a failed cervical exploration and extracted from the record of an actual patient who underwent such a process at the University of Vermont, Burlington, in 1995. In addition, the records of 2 patients with intrathyroidal adenomas were submitted to the same theoretical cost analysis with the exception that these patients were assumed to have adenomas that could be discovered after prolonged cervical exploration and thyroid lobectomy. The net management and imaging costs for 4 cases of ectopic parathyroid adenomas undergoing theoretical failed exploration are compared with the cost of obtaining routine technetium Tc 99m sestamibi and ultrasound scans for each of the 59 patients.
The added cost of protracted or failed cervical exploration nearly neutralized the costs of a routine preoperative localization with technetium Tc 99m sestamibi and ultrasound scans.
评估在未进行术前定位的情况下进行探查时未能识别异位甲状旁腺腺瘤的累积成本,并将这些成本与每位患者进行常规术前定位的费用进行比较。
对连续59例原发性甲状旁腺功能亢进患者进行成本分析,这些患者术前使用锝Tc 99m甲氧基异丁基异腈和超声进行扫描。对5例异位腺瘤病例进行了类似分析,这些病例在常规手术中被认为无法识别。
学术性三级转诊中心。
将探查失败的手术、麻醉、住院、影像检查和医生报销费用与每位患者术前锝Tc 99m甲氧基异丁基异腈和超声扫描的费用进行比较。
在这连续59例患者中,有2例纵隔甲状旁腺腺瘤给出了理论成本,包括住院、医生报销和麻醉费用。这些成本基于颈部探查失败,并从1995年在佛蒙特大学伯灵顿分校接受此类手术的一名实际患者的记录中提取。此外,对2例甲状腺内腺瘤患者的记录进行了相同的理论成本分析,但这些患者被假定患有在长时间颈部探查和甲状腺叶切除术后才能发现的腺瘤。将4例理论上探查失败的异位甲状旁腺腺瘤的净管理和影像检查成本与59例患者中每例患者进行常规锝Tc 99m甲氧基异丁基异腈和超声扫描的成本进行比较。
延长的或失败的颈部探查增加的成本几乎抵消了使用锝Tc 99m甲氧基异丁基异腈和超声扫描进行常规术前定位的成本。